Skip to main content

Efficacy and Safety of Saccharomyces boulardii in Acute Childhood Diarrhea: A Double Blind Randomised Controlled Trial



To see the efficacy and safety of 250 mg of Saccharomyces boulardii twice daily for 5 d in acute childhood diarrhea.


Children aged between 3 mo and 59 mo with acute onset diarrhea (of less than 48 h) admitted in DTTU (diarrhea treatment and training unit) were included and those with clinical evidence of severe malnutrition, systemic infection, encephalopathy and/or convulsion, electrolyte imbalance, invasive diarrhea or previous use of any probiotics were excluded from the study. Those included randomly were given either a placebo or Saccharomyces boullardi (SB) in identical packets mixed with puffed rice powder.


Mean post intervention duration of diarrhea was significantly (95% CI = −28.13 to −5.43) shorter in SB group (52.08 ± 24.57 h) as compared to placebo group (64.04 ± 30.43 h). The time of appearance of first semi formed stool in SB group (39.48 ± 23.09 h) was significantly (95% CI −25.4 to −3.87) shorter than the placebo group (54.13 ± 28.21 h). No statistically significant difference was found in rest of the parameters.


There is initial evidence available that SB may have a therapeutic role in the management of acute childhood diarrhea.

This is a preview of subscription content, access via your institution.


  1. 1.

    Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ. 2003;81:197–204.

    PubMed  Google Scholar 

  2. 2.

    O'Ryan M, Prado V, Pickering LK. A millennium update on pediatric diarrheal illness in the developing world. Semin Pediatr Infect Dis. 2005;16:125–36.

    PubMed  Article  Google Scholar 

  3. 3.

    Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhoea in children: a meta-analysis. Dig Dis Sci. 2002;11:2625–3634.

    Article  Google Scholar 

  4. 4.

    Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhoea in children:a meta-analysis. Pediatrics. 2002;109:678–84.

    PubMed  Article  Google Scholar 

  5. 5.

    McFarland LV, Elmer GW, McFarland M. Meta-analysis of Probiotics for the prevention and treatment of Acute Pediatric Diarrhea. Int J Probiotics Prebiotics. 2006;1:63–76.

    Google Scholar 

  6. 6.

    Cetina-Sauri G, Sierra Basto G. Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea. Annales De Pediatrie. 1994;41:397–400.

    Google Scholar 

  7. 7.

    Hafeez A, Tariq P, Ali S, Kundi ZU, Khan A, Hassan M. The efficacy of saccharomyces boulardii in the treatment of acute watery diarrhea of children: A multicentre randomized controlled trial. J Coll Physicians Surg Pak. 2002;12:432–4.

    Google Scholar 

  8. 8.

    Kurugol Z, Koturoglu G. Effect of Saccharomyces boulardii in children with acute diarrhoea. Acta Pediatr. 2005;94:44–7.

    Article  CAS  Google Scholar 

  9. 9.

    Billo AG, Memon MA, Khaskheli SA, et al. Role of probiotic (Saccharomics boulardii) in management and prevention of diarrhea. World J Gastroenterol. 2006;12:4557–60.

    Google Scholar 

  10. 10.

    Villarruel G, Rubio DM, Lopez F, et al. Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study. Acta Pediatr. 2007;96:538–41.

    Article  Google Scholar 

  11. 11.

    Htwe K, Yee KS, Tin M, Vandenplas Y. Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: A randomized controlled study. Am J Trop Med Hyg. 2008;78:214–6.

    PubMed  Google Scholar 

  12. 12.

    Eren M, Dinleyici EC, Vandenplas Y. Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study. Am J Trop Med Hyg. 2010;82:488–91.

    PubMed  Article  Google Scholar 

  13. 13.

    Le Luyer B, Makhoul G, Duhamel JF. A multicentric study of a lactose free formula supplemented with Saccharomyces boulardii in children with acute diarrhea. Arch Pediatr. 2010;17:459–65.

    PubMed  Article  Google Scholar 

Download references

Conflict of Interest


Role of Funding Source


Author information



Corresponding author

Correspondence to Seema Alam.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Riaz, M., Alam, S., Malik, A. et al. Efficacy and Safety of Saccharomyces boulardii in Acute Childhood Diarrhea: A Double Blind Randomised Controlled Trial. Indian J Pediatr 79, 478–482 (2012).

Download citation


  • Acute diarrhea
  • Probiotics
  • Saccharomyces boularrdii
  • Therapeutic role